Global University Venturing

These are the spinouts that caught our eye over the past month. Here's why they should be on your radar, too.

For corporate venturers, is it better to invest directly from a corporation’s balance sheet or from a stand-alone fund?

Innovation seems threatening to legacy thinking in the region, preventing corporates from going into high-performance mode.

Amid a general downturn, spinouts have been faring much better than the startup world at large.

Launched just a year ago to build on work at Weill Cornell Medicine and New York-Presbyterian Hospital, Cleerly has now closed an oversubscribed series C round.

The dollar valuation of corporate-backed deals in the energy sector dropped sharply in Q2. Cleantech deals are the only exception.

There has never been a better time for corporates to invest in this sector, says Meghan Sharp, Global head of Decarbonization Partners.

But there are other benefits for both sides, researchers find.

Paul Jacquin, co-founder of Randstad Innovation Fund explains how to navigate — and invest in — the future of work.